This job has expired

Medical Director SERM

Employer
Seagen
Location
Bothell, Washington State
Salary
Competitive pay, 401k, Medical/Dental/Vision benefits
Closing date
Jul 30, 2022

View more

Position
Medical Director
Category
Biotechnology
Hours
Full Time
Education
MD
You need to sign in or create an account to save a job.

Job Details

Summary:  

The Medical Director, Safety Evaluation & Risk Management will be responsible for signal detection and aggregate safety assessment for global pharmacovigilance and risk management for assigned Seagen, Inc. investigational and/or marketed products. The successful candidate will serve as a member of the Global Safety Risk Management department and function in a company matrix team environment interacting with several key internal stakeholder groups including; Clinical Affairs, Medical Affairs, Regulatory Affairs, Quality Assurance, Commercial, Research and Legal. 

Responsibilities:  

  • Represent Global Safety in Clinical Sub Team and Study teams for assigned investigational products providing expert medical guidance regarding safety issues 
  • Review and provide analysis for the support of key study-related documents, e.g., IB, ICF, SMC/IDMC 
  • Participate in protocol development to ensure alignment with risk management plans and effective collection of safety data 
  • Represent Global Safety in data standards committee 
  • Participate in the Signal Management System with regular review of safety data for assigned products for identification and evaluation of new safety signals 
  • Responsible for safety data review - to include individual case review and aggregate safety assessment and analysis using safety data from clinical trials or post-marketing sources
  • Perform/provide oversight for medical review of individual safety reports from clinical trials or post-marketing sources 
  • Contribute to preparation and review of periodic reports (PADER; PSUR; Annual IND report; 6-monthly line-listings; EU Annual Safety Report; DSUR) 
  • Participate in production and maintenance of risk management plans and safety communication (marketing applications, company core safety information, regulatory safety queries, etc.) to regulatory agencies or third parties 

Qualifications: 

  • MD (board certified/board eligible or ex-US equivalent) 
  • Proficiency in use of Excel and Microsoft Office 
  • Minimum 3 years of clinical practice experience. Oncology safety science experience preferred 
  • Training in clinical research experience desired 
  • Clinical data collection, assessment, and analysis 
  • Excellent interpersonal skills & ability to work effectively cross culturally and cross functionally 
  • Excellent written and spoken English 

 

As the leading employer in our industry in the Pacific Northwest, Seagen is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Seagen, please visit www.seagen.com.  

Seagen is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.  

To prevent the spread of COVID-19, and as an integral part of its public health and safety measures, Seagen requires that all newly-hired employees be fully vaccinated against COVID-19 before commencing employment, subject to reasonable accommodation and other requirements of applicable federal, state, and local law. 

Company

Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer.

As an industry leader in antibody–drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies designed to deliver cell-killing agents to cancer cells. Three of our four approved medicines are built on this technology.

We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.

Find Us
Website
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert